NCT03404544View on ClinicalTrials.gov

Impact of Carbetocin Administration on Heart Rate When Given as an Infusion Versus as a Bolus.

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

June 11, 2018

Primary Completion Date

January 28, 2020

Study Completion Date

January 15, 2021

Conditions
Cesarean Section ComplicationsHemodynamic Instability
Interventions
DRUG

Carbetocin bolus

Carbetocin 100 mcg intravenous as a bolus (less than 2 sec)

DRUG

Carbetocin infusion

Carbetocin 100 mcg intravenous as a 10 minutes infusion

Trial Locations (1)

H1T2M4

CIUSSS de l'Est de l'Ile de Montreal, Montreal

All Listed Sponsors
lead

Ciusss de L'Est de l'Île de Montréal

OTHER

NCT03404544 - Impact of Carbetocin Administration on Heart Rate When Given as an Infusion Versus as a Bolus. | Biotech Hunter | Biotech Hunter